Ramesh Kumar - 16 Dec 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Reporting relationship: Director
Issuer ticker: OCGN
Reported as of: 16 Dec 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Dec 2021, 20:23:19 UTC
Prior SEC filing: 20 Oct 2021
Next SEC filing: 20 Jan 2022
Source filing: View source filing
Reporting owner signature: By: /s/ Ramesh Kumar by Sanjay Subramanian, his attorney-in-fact

Key filing fact

Ramesh Kumar filed Form 4 for Ocugen, Inc. (OCGN) on 17 Dec 2021.

Key facts

This page summarizes Ramesh Kumar's Form 4 filing for Ocugen, Inc. (OCGN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Dec 2021, 20:23.

Change

Previous filing in this sequence was filed on 20 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OCGN transaction Derivative

Option (Right to Buy)

Award

Transaction value: $0
Shares: +16,335
Change %
Price: $0.000000
Shares after: 16,335
Date: 16 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,335
Exercise price: $5.02
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests monthly in equal installments over three years commencing on January 16, 2022, subject to continued service with Ocugen, Inc. on the applicable vesting dates.